Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

There is no single genetic blueprint for cancer. Instead, each individual cancer draws on a collection of acquired mutations that endow the cells with a selective advantage and superior immune evasion ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

The study could distinguish cancer and normal cells by scanning as few as 250 RNA molecules obtained from tissue samples. This is a fraction of what a typical nanopore sequencing device is capable of.

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant or postpartum women who initially received unusual or nonreportable ...

Supported by the BBVA Foundation to C.M.C.; ISCIII (PI22_00720), Asociación Española Contra el Cáncer (AECC CLSEN20004SERR), and CRIS Cancer Foundation (excellence2023_44), all to C.S. The following ...

Virginia G. Kaklamani, MD, DSc, discusses datopotamab deruxtecan and other antibody-drug conjugates available for patients with unresectable or metastatic hormone receptor-positive, HER2-negative ...

Alec Kimmelman, MD, PhD, and Shridar Ganesan, MD, PhD, discuss the institution's new molecular oncology program.

Peter Campbell is head of cancer, aging, and somatic mutation, senior group leader, and joint head of the Cancer Genome Project at the Wellcome Trust Sanger Institute and is a practicing ...

Novel technologies were added when developing an innovative vivarium for a prominent Boston cancer research organization to ...

A revolutionary blood test, TriOx, developed by researchers at the University of Oxford, is demonstrating significant ...